The Observational Study of Growth Hormone-secreting Pituitary Tumors
NCT01368133 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2013-09-26
Summary
The major purpose of this study is to evaluate the changes of multiple organs in patients with growth hormone-secreting pituitary tumors before and after surgery. Plasma, DNA samples and pituitary tumor tissues will be kept for further analysis.
Conditions
- Acromegaly
- Pituitary Tumor
Sponsors & Collaborators
-
National Natural Science Foundation of China
collaborator OTHER_GOV -
Huashan Hospital
lead OTHER
Principal Investigators
-
Yao Zhao, M.D. · Huashan Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-05-31
- Primary Completion
- 2013-12-31
- Completion
- 2013-12-31
Countries
- China
Study Locations
More Related Trials
-
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors
NCT01568359 ·Status: COMPLETED
-
Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas
NCT00646308 ·Status: TERMINATED
-
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
NCT00001595 ·Status: RECRUITING
-
Measurement of Outcome of Surgical Treatment in Patients With Acromegaly
NCT00005100 ·Status: UNKNOWN
-
Detailed Clinical, Biochemical and Genetic Characterization in Gonadotropin-releasing Hormone (GnRH) Deficiency Disorders
NCT01165619 ·Status: TERMINATED
-
Setting Benchmarks for Transsphenoidal Resection of Pituitary Adenomas
NCT04951557 ·Status: UNKNOWN
-
A Pilot Study of Rosiglitazone in the Treatment of GH Secreting Pituitary Adenomas
NCT03309319 ·Status: UNKNOWN ·Phase: NA
-
Transsphenoidal Extent of Resection Study
NCT02357498 ·Status: COMPLETED ·Phase: NA
-
Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly
NCT00004332 ·Status: COMPLETED
-
Follow-up Evaluation of Photo-Dynamic Therapy for Pituitary Tumours
NCT02632084 ·Status: COMPLETED
-
Preoperative Octreotide Treatment of Acromegaly
NCT00521300 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors
NCT07335315 ·Status: RECRUITING
-
Next Day Growth Hormone Predicting Pituitary Function After Adenomectomy
NCT03708523 ·Status: UNKNOWN
-
Pituitary Histopathology and Hyperprolactinaemia and Risk of Glucose Metabolic Disturbances in Acromegaly.
NCT02092129 ·Status: UNKNOWN
-
Hydrocortisone Use During Peri-operation for Pituitary Adenomas
NCT04621565 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasia
NCT05353192 ·Status: UNKNOWN ·Phase: PHASE4
-
Modulating the GIP System in Patients With Acromegaly Due to a Pituitary Tumor
NCT03807076 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Pulsatile GnRH Therapy on Male Patients With Pituitary Stalk Interruption Syndrome
NCT02705014 ·Status: UNKNOWN ·Phase: NA
-
The Longitudinal Approach to Acromegaly: A Pattern of Treatment and Comparative Effectiveness Research
NCT03158090 ·Status: RECRUITING
-
Description of Sign-and-symptom Associations at Acromegaly Diagnosis.
NCT02012127 ·Status: COMPLETED
-
Cellular, Molecular and Clinical Determinants of Bone Strength in in Vivo and Human Models of GH Excess.
NCT06344650 ·Status: RECRUITING
-
National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients
NCT00097513 ·Status: COMPLETED
-
Pituitary Adenoma and Serum Lipid
NCT04021212 ·Status: UNKNOWN
-
Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models
NCT06326853 ·Status: NOT_YET_RECRUITING
-
Peri-Operative Steroid Management in Patients
NCT02084134 ·Status: COMPLETED ·Phase: NA